AR and prostate carcinoma: Derived from an omental fat metastasis of a prostate carcinoma exhibiting a major small-cell/neuroendocrine component, the LuCaP49 PDX model lacks expression of PSA and AR and is characterized by insensitivity to androgen deprivation and rapid tumor growth14.